サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：インスリンポンプ市場：タイプ・製品・付属品・疾患・年齢層・エンドユーザー・流通チャネル・地域別、機会、予測、2017年～2031年
市場調査レポート
商品コード
1422072

インスリンポンプ市場：タイプ・製品・付属品・疾患・年齢層・エンドユーザー・流通チャネル・地域別、機会、予測、2017年～2031年

Insulin Pumps Market Assessment, By Type, By Product, By Accessories, By Disease Indication, By Age Group, By End-user, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 219 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
インスリンポンプ市場：タイプ・製品・付属品・疾患・年齢層・エンドユーザー・流通チャネル・地域別、機会、予測、2017年～2031年
出版日: 2024年02月07日
発行: Market Xcel - Markets and Data
ページ情報: 英文 219 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のインスリンポンプの市場規模は、2023年の67億8,000万米ドルから、予測期間中は12.28%のCAGRで推移し、2031年には171億2,000万米ドルの規模に成長すると予測されています。

市場成長を推進している主な要因には、糖尿病有病率の急増、利便性と使いやすさを提供するインスリン送達デバイスに対するニーズの高まり、技術の進歩、政府の取り組み、高齢者人口の増加などがあります。

糖尿病有病率の上昇

世界の糖尿病患者数は過去30年間で大幅に増加し、1億800万人から4億2,000万人に急増しました。このうち6,200万人が南北アメリカの糖尿病患者であり、世界のインスリンポンプ市場に大きな影響を与えています。注目すべきは、1980年以降、この地域でその数が3倍以上に膨れ上がっていることで、実際の数字はもっと高い可能性があります。糖尿病に関連する健康問題がもたらす負担は、重大であり、かつ深刻化しています。20年の間に、糖尿病に関連した死亡率は世界で70％も増加しています。

インスリン自動投与アルゴリズムへの需要の高まり

インスリン自動投与アルゴリズムへの要望の高まりは、糖尿病治療における重要な転換を意味します。先進技術を駆使したこれらのアルゴリズムは、正確で適応性の高いインスリンコントロールを提供します。世界の糖尿病有病率の上昇に伴い、インスリン管理を簡素化し改善するための独創的なソリューションに対する需要が顕著になっています。

政府の取り組み

政府の取り組みは、アクセシビリティ、価格、先進技術の導入に影響を与えており、インスリンポンプ市場の特性を形成する上で中心的なものです。これらの政府の努力は、膨大な世界人口を苦しめる糖尿病の問題に対応するために不可欠です。政府が患者による自己管理を支援する度合いが高いほど、長期的なヘルスケアコストが削減されることになります。

当レポートでは、世界のインスリンポンプの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のインスリンポンプ市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のインスリンポンプ市場の展望

  • 市場規模・予測
  • タイプ別
    • スタンドアロン型インスリンポンプ
    • センサー一体型インスリンポンプ
  • 製品別
    • ポンプ
    • 消耗品
  • 付属品別
    • インスリンリザーバーまたはカートリッジ
    • インスリンセット挿入デバイス
    • 電池
  • 疾患別
    • 1型糖尿病
    • 2型糖尿病
  • 年齢層別
    • 成人
    • 小児
    • 両方
  • エンドユーザー別
    • 病院
    • クリニック
    • 家庭用
    • ラボ
  • 流通チャネル別
    • 小売店
    • 病院薬局
    • eコマース
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 企業別市場シェア

第6章 世界のインスリンポンプ市場の見通し：地域別

  • 北米
  • 欧州
  • 南米
  • アジア太平
  • 中東・アフリカ

第7章 市場マッピング

  • タイプ別
  • 製品別
  • 付属品別
  • 疾患別
  • 年齢層別
  • エンドユーザー別
  • 流通チャネル別
  • 地域別

第8章 マクロ環境と産業構造

  • 需給分析
  • 輸出入分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長推進因子
  • 成長抑制因子 (課題・障壁)

第9章 規制の枠組み・イノベーション

  • 臨床試験
  • 特許の情勢
  • 規制当局の承認
  • イノベーション/最新技術

第10章 主要企業の情勢

  • 市場リーダー上位5社の競合マトリックス
  • 市場リーダー上位5社の市場収益分析
  • M&A・ジョイントベンチャー (該当する場合)
  • SWOT分析 (参入5社)
  • 特許分析 (該当する場合)

第11章 価格分析

第12章 ケーススタディ

第14章 主要企業の見通し

  • Medtronic plc.
  • Abbott Laboratories
  • Ypsomed AG
  • CamDiab Ltd.
  • Phillips-Medisize Corporation
  • Modular Medical, Inc.
  • Tandem Diabetes Care, Inc.
  • Roche Diabetes Care, Inc.
  • Beta Bionics
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • WUXI APEX Medical Corporation
  • SOOIL Developments Co., Ltd.

第15章 戦略的提言

第16章 当社について・免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 5. Global Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 6. Global Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 7. Global Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 8. Global Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 10. Global Insulin Pumps Market Share (%), By Region, 2017-2031F
  • Figure 11. North America Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. North America Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 13. North America Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 14. North America Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 15. North America Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 16. North America Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 17. North America Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 18. North America Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 19. North America Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 20. North America Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 21. United States Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. United States Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 23. United States Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 24. United States Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 25. United States Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 26. United States Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 27. United States Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 28. United States Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 29. United States Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 30. Canada Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 31. Canada Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 32. Canada Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 33. Canada Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 34. Canada Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 35. Canada Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 36. Canada Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 37. Canada Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 38. Canada Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 39. Mexico Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. Mexico Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 41. Mexico Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 42. Mexico Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 43. Mexico Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 44. Mexico Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 45. Mexico Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 46. Mexico Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 47. Mexico Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 48. Europe Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Europe Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 50. Europe Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 51. Europe Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 52. Europe Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 53. Europe Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 54. Europe Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 55. Europe Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 56. Europe Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 57. Europe Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 58. Germany Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. Germany Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 60. Germany Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 61. Germany Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 62. Germany Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 63. Germany Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 64. Germany Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 65. Germany Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 66. Germany Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 67. France Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. France Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 69. France Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 70. France Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 71. France Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 72. France Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 73. France Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 74. France Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 75. France Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 76. Italy Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Italy Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Italy Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 79. Italy Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 80. Italy Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 81. Italy Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 82. Italy Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 83. Italy Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 84. Italy Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 85. United Kingdom Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. United Kingdom Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 87. United Kingdom Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 88. United Kingdom Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 89. United Kingdom Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 90. United Kingdom Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 91. United Kingdom Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 92. United Kingdom Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 93. United Kingdom Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. Russia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Russia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 96. Russia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 97. Russia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 98. Russia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 99. Russia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 100. Russia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 101. Russia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 102. Russia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 103. Netherlands Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 104. Netherlands Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 105. Netherlands Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 106. Netherlands Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 107. Netherlands Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 108. Netherlands Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 109. Netherlands Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 110. Netherlands Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 111. Netherlands Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 112. Spain Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 113. Spain Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 114. Spain Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 115. Spain Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 116. Spain Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 117. Spain Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 118. Spain Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 119. Spain Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 120. Spain Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 121. Turkey Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Turkey Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 123. Turkey Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 124. Turkey Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 125. Turkey Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 126. Turkey Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 127. Turkey Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 128. Turkey Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 129. Turkey Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 130. Poland Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 131. Poland Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 132. Poland Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 133. Poland Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 134. Poland Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 135. Poland Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 136. Poland Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 137. Poland Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 138. Poland Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 139. South America Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. South America Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 141. South America Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 142. South America Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 143. South America Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 144. South America Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 145. South America Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 146. South America Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 147. South America Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 148. South America Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 149. Brazil Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 150. Brazil Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 151. Brazil Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 152. Brazil Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 153. Brazil Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 154. Brazil Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 155. Brazil Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 156. Brazil Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 157. Brazil Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 158. Argentina Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 159. Argentina Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 160. Argentina Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 161. Argentina Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 162. Argentina Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 163. Argentina Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 164. Argentina Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 165. Argentina Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 166. Argentina Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 167. Asia-Pacific Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Asia-Pacific Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 169. Asia-Pacific Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 170. Asia-Pacific Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 171. Asia-Pacific Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 172. Asia-Pacific Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 173. Asia-Pacific Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 174. Asia-Pacific Insulin Pumps Market Share (%), By End-user, In USD Billion, 2016-2030
  • Figure 175. Asia-Pacific Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 176. Asia-Pacific Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 177. India Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 178. India Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 179. India Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 180. India Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 181. India Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 182. India Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 183. India Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 184. India Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 185. India Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 186. China Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 187. China Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 188. China Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 189. China Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 190. China Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 191. China Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 192. China Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 193. China Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 194. China Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Japan Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Japan Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 197. Japan Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 198. Japan Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 199. Japan Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 200. Japan Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 201. Japan Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 202. Japan Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 203. Japan Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 204. Australia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 205. Australia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 206. Australia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 207. Australia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 208. Australia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 209. Australia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 210. Australia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 211. Australia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 212. Australia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 213. Vietnam Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 214. Vietnam Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 215. Vietnam Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 216. Vietnam Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 217. Vietnam Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 218. Vietnam Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 219. Vietnam Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 220. Vietnam Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 221. Vietnam Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 222. South Korea Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 223. South Korea Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 224. South Korea Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 225. South Korea Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 226. South Korea Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 227. South Korea Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 228. South Korea Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 229. South Korea Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 230. South Korea Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 231. Indonesia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 232. Indonesia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 233. Indonesia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 234. Indonesia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 235. Indonesia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 236. Indonesia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 237. Indonesia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 238. Indonesia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 239. Indonesia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 240. Philippines Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 241. Philippines Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 242. Philippines Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 243. Philippines Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 244. Philippines Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 245. Philippines Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 246. Philippines Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 247. Philippines Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 248. Philippines Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 249. Middle East & Africa Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 250. Middle East & Africa Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 251. Middle East & Africa Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 252. Middle East & Africa Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 253. Middle East & Africa Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 254. Middle East & Africa Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 255. Middle East & Africa Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 256. Middle East & Africa Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 257. Middle East & Africa Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 258. Middle East & Africa Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 259. Saudi Arabia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 260. Saudi Arabia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 261. Saudi Arabia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 262. Saudi Arabia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 263. Saudi Arabia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 264. Saudi Arabia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 265. Saudi Arabia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 266. Saudi Arabia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 267. Saudi Arabia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 268. UAE Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 269. UAE Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 270. UAE Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 271. UAE Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 272. UAE Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 273. UAE Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 274. UAE Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 275. UAE Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 276. UAE Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 277. South Africa Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 278. South Africa Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 279. South Africa Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 280. South Africa Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 281. South Africa Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 282. South Africa Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 283. South Africa Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 284. South Africa Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 285. South Africa Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 287. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 288. By Accessories Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 289. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 290. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 291. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 292. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 293. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX10937

Global insulin pumps market size was valued at USD 6.78 billion in 2023, which is expected to reach USD 17.12 billion in 2031, with a CAGR of 12.28% for the forecast period between 2024 and 2031F. The key factors propelling the global insulin pumps market include a surge in the prevalence of diabetes, a growing need for insulin delivery devices that offer convenience and user-friendliness, advancements in technology, governmental efforts, and an increasing elderly population.

The global insulin pumps market is expected to gain a substantial transformation and expansion, driven by a convergence of factors that are reshaping the realm of diabetes management. One of the principal catalysts propelling the market's growth is the escalating prevalence of diabetes. The alarming surge in diabetes cases, encompassing both type 1 and type 2, has generated an urgent requirement for dependable and convenient means of administering insulin. As patients and healthcare practitioners seek more efficacious methods for regulating blood glucose levels, insulin pumps have emerged as the favored choice due to their capacity to deliver precise doses with minimal exertion.

Moreover, the global insulin pumps market is capitalizing on technological advancements. The incorporation of continuous glucose monitoring (CGM), the emergence of intelligent insulin pumps, and improvements in user interfaces have transformed these devices into more user-friendly and efficient tools. Patients are increasingly in search of devices that provide precise insulin delivery and seamlessly integrate with smartphones and other digital platforms, enabling real-time data monitoring and management.

Additionally, governmental efforts aimed at alleviating the diabetes burden and associated healthcare costs are fostering the global insulin pumps market's growth. Public health initiatives and policies designed to encourage the adoption of advanced diabetes management technologies have contributed to heightened accessibility and affordability of insulin pumps.

Rising Diabetes Prevalence

Globally, the population of individuals living with diabetes (PLWD) has witnessed a substantial surge over the past three decades, soaring from 108 million to 420 million. Among these, 62 million individuals with diabetes reside in the Americas, largely impacting the global insulin pumps market. Notably, the number has ballooned by more than threefold in the region since 1980, with the actual figure being potentially higher, as 40% of PLWD remain unaware of their condition, going undiagnosed. The burden posed by diabetes-related health issues is both significant and escalating. Within two decades, diabetes-related mortality has escalated by a staggering 70% worldwide.

In the Americas, it stands as the sixth leading cause of death and the seventh leading contributor to years of life lost prematurely. In the region, diabetes, inclusive of diabetes-related kidney disease, accounts for the premature loss of more than eight million years of life annually. Astonishingly, almost half of premature deaths in the Americas are attributed to diabetes. Furthermore, over a span of just 20 years, the number of disability-adjusted life years (DALYs) attributable to diabetes has surged by 88%, reaching a remarkable 97% increase among men. Presently, diabetes ranks as the second leading cause of DALYs globally, trailing behind ischemic heart disease.

Rising Demand for Algorithms for Automated Insulin Delivery

The increasing desire for algorithms in automated insulin delivery signifies a significant shift in diabetes care. These algorithms, powered by advanced technologies, offer precise and adaptable insulin control. With the global diabetes prevalence on the rise, there's a pronounced demand for inventive solutions to simplify and improve insulin management. The growing demand for insulin delivery algorithms is opening doors for companies specializing in these technologies. Firms capable of creating precise, dependable, and user-friendly algorithms are poised to thrive in the expanding global insulin pumps market. As an example, in May 2023, Beta Bionics obtained approval from the US Food and Drug Administration (FDA) for its iLet ACE Pump and iLet Dosing Decision Software, designed for individuals aged six years and older with type 1 diabetes. These components, when used in conjunction with a compatible integrated continuous glucose monitor (iCGM), constitute the iLet Bionic Pancreas system. The innovative system employs an algorithm to assess and regulate insulin delivery.

Government Initiatives

Government actions are central in molding the global insulin pumps market's characteristics, impacting its accessibility, affordability, and the uptake of advanced technologies for managing diabetes. These governmental endeavors are vital in confronting the escalating issue of diabetes, a persistent metabolic ailment marked by elevated blood glucose levels that afflict a vast global population. The greater the extent to which governments can assist patients in acquiring the skills for self-management, the lower the long-term healthcare costs it will incur due to improved health outcomes and reduced costs for the entire population.

For instance, in March 2023, the government of New Brunswick unveiled its plan to alleviate the financial burden associated with diabetes. Minister of Finance Ernie Steeves announced a budget allocation of USD 2.1 million to improve diabetes management. In New Brunswick, annual expenses directly borne by individuals can surpass USD 18,000 for those with Type 1 diabetes and USD 10,000 for those with Type 2 diabetes, as reported by Diabetes Canada. The province's announcement is expected to target and alleviate a significant portion of the high costs linked with diabetes.

Growing Demand for Insulin Patch

The increasing desire for insulin patches marks a noteworthy transformation in the global insulin pump market. Insulin patches present a non-intrusive and unobtrusive means of administering insulin, potentially enhancing the well-being of individuals living with diabetes. The surging appeal of these patches can be traced to their convenience, precision, and ability to address certain obstacles linked to conventional insulin delivery approaches.

As an illustration, in May 2023, Medtronic plc, a prominent player in healthcare technology, disclosed its intent to finalize a series of agreements aimed at acquiring EOFlow Co. Ltd., the creator of the EOPatch device, an insulin delivery device that is both tubeless and disposable, designed to be worn on the body. The incorporation of EOFlow into Medtronic's portfolio, in conjunction with the company's Meal Detection Technology algorithm and state-of-the-art continuous glucose monitor (CGM), is poised to enhance Medtronic's capacity to cater to the diverse requirements of individuals with diabetes, regardless of their stage in the treatment process or their preferences for insulin delivery methods. Such convenience-based products are the leading cause for drastic growth in global insulin pump market.

Increasing Demand for Type 1 Diabetes Solutions

The intricate challenges of mealtimes in type 1 diabetes management drive the demand for solutions and stimulate growth in the global insulin pumps market. Balancing insulin dosages with carbohydrate intake, managing blood sugar spikes post-meal, and predicting meal content can be formidable tasks. The challenge lies in maintaining glycemic control and preventing hypoglycemia or hyperglycemia during and after meals. CGM, advanced insulin delivery systems, and mealtime planning have become essential strategies to address these challenges and enhance diabetes management. As an example, in April 2023, Medtronic plc, a leading global medical technology company, revealed that the U.S. Food and Drug Administration (FDA) had approved its MiniMed 780G system, featuring the Guardian 4 sensor, which eliminates the need for fingerstick tests when using SmartGuard technology. This achievement signifies the approval of the sole system incorporating meal detection technology, enabling automatic adjustments and corrections to sugar levels every 5 minutes, proving highly advantageous for individuals with type 1 diabetes.

Impact of COVID-19

Patients with T1DM using insulin pumps experienced a milder impact from COVID-19 lockdown measures on their glycemic control than those using insulin pens. The adoption of telemedicine and online consultations yielded substantial benefits, optimizing time allocation per patient, and improving physician-patient communication. Physicians could remotely monitor disease progression, resulting in significant improvements. Notably, insulin pump users exhibited superior glycemic stability and better resilience to pandemic-related stress and anxiety compared to pen users. The advantage may be attributed to the continuous glycemic monitoring system, which is likely contributed to fewer hyperglycemic episodes in the group. However, the pandemic had some adverse effects on the global insulin pumps market, as several insulin pump manufacturers deferred or put on hold the introduction of new products or enhancements because of the uncertainties stemming from the pandemic.

Key Players Landscape and Outlook

Collaborative efforts in the global insulin pumps market are witnessing a surge as companies aim to pioneer novel and inventive technologies for the betterment of individuals with diabetes. Recent instances of such collaborations include Medtronic teaming up with Bigfoot Biomedical to co-create a hybrid closed-loop insulin delivery system, and Tandem Diabetes Care partnering with Dexcom to seamlessly integrating their insulin pumps with Dexcom's continuous glucose monitoring (CGM) system. These partnerships are pivotal in expediting the development of next-generation insulin pumps characterized by enhanced accuracy, convenience, and user-friendliness.

For example, in August 2023, Modular Medical, Inc. joined forces with Phillips-Medisize to broaden the array of insulin delivery options. Leveraging its extensive and diverse supplier network, as well as its profound expertise in medical devices and diabetes management, Phillips-Medisize took charge of designing and developing the manufacturing and assembly processes for the MODD1 Insulin Delivery System. The collaboration has expedited the development journey for Modular Medical and has paved the way for substantial scalability and a state of readiness for market launch.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on Global Insulin Pumps Market

4. Executive Summary

5. Global Insulin Pumps Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Standalone Insulin Pumps
    • 5.2.2. Sensor Integrated Insulin Pumps
  • 5.3. By Product
    • 5.3.1. Pumps
      • 5.3.1.1. Tethered Pumps
      • 5.3.1.2. Patch Pumps
      • 5.3.1.3. Others
    • 5.3.2. Consumables
  • 5.4. By Accessories
    • 5.4.1. Insulin Reservoir or Cartridges
    • 5.4.2. Insulin Set Insertion Devices
    • 5.4.3. Battery
  • 5.5. By Disease Indication
    • 5.5.1. Type 1 Diabetes
    • 5.5.2. Type 2 Diabetes
  • 5.6. By Age Group
    • 5.6.1 Adult
    • 5.6.2. Paediatrics
    • 5.6.3. Both
  • 5.7. By End-user
    • 5.7.1. Hospitals
    • 5.7.2. Clinics
    • 5.7.3. Homeware
    • 5.7.4. Laboratories
  • 5.8. By Distribution Channel
    • 5.6.1 Retail Stores
    • 5.6.2 Hospital Pharmacy
    • 5.6.3 E-commerce
  • 5.9. By Region
    • 5.9.1. North America
    • 5.9.2. South America
    • 5.9.3. Europe
    • 5.9.4. Asia-Pacific
    • 5.9.5. Middle East and Africa
  • 5.10. By Company Market Share (%), 2023

6. Global Insulin Pumps Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. Standalone Insulin Pumps
      • 6.1.2.2. Sensor Integrated Insulin Pumps
    • 6.1.3. Product
      • 6.1.3.1. Pumps
      • 6.1.3.1.1. Tethered Pumps
      • 6.1.3.1.2. Patch Pumps
      • 6.1.3.1.3. Others
      • 6.1.3.2. Consumables
    • 6.1.4. By Accessories
      • 6.1.4.1. Insulin Reservoir or Cartridges
      • 6.1.4.2. Insulin Set Insertion Devices
      • 6.1.4.3. Battery
    • 6.1.5. By Disease Indication
      • 6.1.5.1. Type 1 Diabetes
      • 6.1.5.2. Type 2 Diabetes
    • 6.1.6. By Age Group
      • 6.1.6.1. Adult
      • 6.1.6.2. Pediatric
      • 6.1.6.3. Both
    • 6.1.7. By End-user
      • 6.1.7.1. Hospitals
      • 6.1.7.2. Clinics
      • 6.1.7.3. Homeware
      • 6.1.7.4. Laboratories
    • 6.1.8. By Distribution Channel
      • 6.1.8.1. Retail Stores
      • 6.1.8.2. Hospital Pharmacy
      • 6.1.8.3. E-commerce
    • 6.1.9. United States*
      • 6.1.9.1. Market Size & Forecast
      • 6.1.9.1.1. Value
      • 6.1.9.1.2. Volume
      • 6.1.9.2. By Type
      • 6.1.9.2.1. Standalone Insulin Pumps
      • 6.1.9.2.2. Sensor Integrated Insulin Pumps
      • 6.1.9.3. By Product
      • 6.1.9.3.1. Pumps
      • 6.1.9.3.1.1. Tethered Pumps
      • 6.1.9.3.1.2. Patch Pumps
      • 6.1.9.3.1.3. Others
      • 6.1.9.3.2. Consumables
      • 6.1.9.4. By Accessories
      • 6.1.9.4.1. Insulin Reservoir or Cartridges
      • 6.1.9.4.2. Insulin Set Insertion Devices
      • 6.1.9.4.3. Battery
      • 6.1.9.5. By Disease Indication
      • 6.1.9.5.1. Type 1 Diabetes
      • 6.1.9.5.2. Type 2 Diabetes
      • 6.1.9.6. By Age Group
      • 6.1.9.6.1. Adult
      • 6.1.9.6.2. Pediatric
      • 6.1.9.6.3. Both
      • 6.1.9.7. By End-user
      • 6.1.9.7.1. Hospitals
      • 6.1.9.7.2. Clinics
      • 6.1.9.7.3. Homeware
      • 6.1.9.7.4. Laboratories
      • 6.1.9.8. By Distribution Channel
      • 6.1.9.8.1. Retail Stores
      • 6.1.9.8.2. Hospital Pharmacy
      • 6.1.9.8.3. E-commerce
    • 6.1.10. Canada
    • 6.1.11. Mexico

All segments will be provided for all regions and countries covered:

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Product
  • 7.3. By Accessories
  • 7.4. By Disease Indication
  • 7.5. By Age Group
  • 7.6. By End-user
  • 7.7. By Distribution Channel
  • 7.8. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Medtronic plc.
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Abbott Laboratories
  • 14.3. Ypsomed AG
  • 14.4. CamDiab Ltd.
  • 14.5. Phillips-Medisize Corporation
  • 14.6. Modular Medical, Inc.
  • 14.7. Tandem Diabetes Care, Inc.
  • 14.8. Roche Diabetes Care, Inc.
  • 14.9. Beta Bionics
  • 14.10. Insulet Corporation
  • 14.11. Jiangsu Delfu Medical Device Co., Ltd.
  • 14.12. WUXI APEX Medical Corporation
  • 14.13. SOOIL Developments Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer